The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership
about
Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experienceThe Pharmaceutical Commons: Sharing and Exclusion in Global Health Drug DevelopmentA New Handheld Device for the Detection of Falsified Medicines: Demonstration on Falsified Artemisinin-Based Therapies from the Field.Population pharmacokinetics of mefloquine, administered as a fixed-dose combination of artesunate-mefloquine in Indian patients for the treatment of acute uncomplicated Plasmodium falciparum malaria.An enzymatic platform for the synthesis of isoprenoid precursors.High adherence to malaria treatment: promising results of an adherence study in South Kivu, Democratic Republic of the CongoClinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa.The global pipeline of new medicines for the control and elimination of malariaDegradation of Artemisinin-Based Combination Therapies Under Tropical ConditionsFixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.Capillary electrophoresis for the assay of fixed-dose combination tablets of artesunate and amodiaquine.Needs-driven versus market-driven pharmaceutical innovation: the consortium for the development of a new medicine against malaria in Brazil.Adherence to treatment with artemether-lumefantrine or amodiaquine-artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial.
P2860
Q21034090-7CBC6DD0-5197-470E-81F3-6EE7C4903EB4Q28652305-821BBDEB-3501-4565-9537-2D6CFDF306DEQ33636843-A543475B-7602-4AA6-A795-962C80EF7DC1Q33713272-839B1986-0E34-4E9B-8182-9FB684C3DFC2Q34083903-3D1599AF-71B9-477A-8084-33A85F416230Q36190074-29E8E363-0111-4A30-9267-935BD9EABCB1Q36309115-82EF4AD9-6B52-419A-96A7-87F5B5AFD8BAQ36320249-52A0ED6C-42F1-42A8-A2CF-1B287E935686Q36869659-D3E458A4-0091-4C90-9E68-73BDCC355094Q37560437-84BF1FC2-4781-492A-8E1A-1CDEB6D4A11AQ41915282-BB260E30-8400-46D9-AF50-95EE957BB645Q47864660-A0E73593-2777-471A-BC28-292C7D479CCCQ55491745-71476A13-D891-4446-B1F3-B2A143E3F5AC
P2860
The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The initial pharmaceutical dev ...... : a public-private partnership
@ast
The initial pharmaceutical dev ...... : a public-private partnership
@en
The initial pharmaceutical dev ...... : a public-private partnership
@en-gb
The initial pharmaceutical dev ...... : a public-private partnership
@nl
type
label
The initial pharmaceutical dev ...... : a public-private partnership
@ast
The initial pharmaceutical dev ...... : a public-private partnership
@en
The initial pharmaceutical dev ...... : a public-private partnership
@en-gb
The initial pharmaceutical dev ...... : a public-private partnership
@nl
prefLabel
The initial pharmaceutical dev ...... : a public-private partnership
@ast
The initial pharmaceutical dev ...... : a public-private partnership
@en
The initial pharmaceutical dev ...... : a public-private partnership
@en-gb
The initial pharmaceutical dev ...... : a public-private partnership
@nl
P2093
P2860
P921
P356
P1433
P1476
The initial pharmaceutical dev ...... : a public-private partnership
@en
P2093
Antonella Caminiti
Bellabes Ghezzoul
Catherine Lacaze
Fawaz Fawaz
Jean-René Kiechel
Laurent Terrassin
Luc Grislain
Nick J White
Pascal Millet
Piero L Olliaro
P2860
P2888
P356
10.1186/1475-2875-10-142
P407
P50
P577
2011-01-01T00:00:00Z
P5875
P6179
1052779521